Benefit-Harm assessments
|
|
- Bernice Bell
- 5 years ago
- Views:
Transcription
1 David Coulter NZ Intensive Medicines Monitoring Programme 27 March 2003 Lusaka 1
2 Introduction 1 Medicines are an important cause of harm. In many western countries adverse reactions account for about 6% of hospital admissions and about another 6% of patients develop reactions in hospital. But they also do good and save lives! 27 March 2003 Lusaka 2
3 Introduction 2 How do we assess that they do more good than harm? How do we make an appropriate balance between benefit and harm? This needs to be assessed on a population basis. It also needs to be assessed for each individual patient. 27 March 2003 Lusaka 3
4 Introduction 3 Can we accept that a drug causes benefit in many at the cost of serious injury in some? The answer will change for each disease being treated and for each population or person being treated. 27 March 2003 Lusaka 4
5 Introduction 4 If a disease is fatal and there is a chance of cure, greater risk may be acceptable. If a disease has a good outcome without treatment, then little risk can be accepted. 27 March 2003 Lusaka 5
6 Introduction 5 On a population basis, this is a public health problem and the assessment is important to drug regulatory authorities. On an individual patient basis, a decision on the balance of benefit and harm needs to be made by the physician and patient. 27 March 2003 Lusaka 6
7 Introduction 6 Pharmacovigilance: Basic introduction and specifics for malaria programme Plane crash Missiles SARS (severe acute respiratory syndrome) Is it worth the risk of harm? 27 March 2003 Lusaka 7
8 Introduction 7 How does the drug score in terms of efficacy (benefit) and safety? 27 March 2003 Lusaka 8
9 Assessment 1 Benefit mean level of improvement in users duration of improvement proportion of users with improvement Harm seriousness of reaction(s) outcome frequency 27 March 2003 Lusaka 9
10 Assessment 2 Problem: there is usually insufficient knowledge to make a definitive, objective assessment Efficacy -clinical trials do not reflect what might happen in the real world. Harm-adverse reaction data are usually incomplete and imprecise and unmeasurable. 27 March 2003 Lusaka 10
11 Assessment 3 Principle of Threes 1 Disease 2 Improvement produced by the drug 3 Adverse effects of the drug 27 March 2003 Lusaka 11
12 Assessment 4 1 Seriousness 2 Duration 3 Incidence Principle of Threes -Disease 27 March 2003 Lusaka 12
13 Assessment 5 Principle of Threes -Improvement produced by the drug 1 Seriousness (level of improvement) 2 Duration 3 Incidence 27 March 2003 Lusaka 13
14 Assessment 6 1 Seriousness 2 Duration 3 Incidence Principle of Threes -Adverse effects of the drug 27 March 2003 Lusaka 14
15 Assessment 7 Score High=3 Medium=2 Low=1 Seriousness Fatal Disabling Inconvenient Duration Permanent Persistent Temporary Incidence Common Frequent Rare 27 March 2003 Lusaka 15
16 Assessment 8 RESOURCES CIOMS Working Group IV, Benefit-Risk Balance for Marketed Drugs: Evaluating Safety Signals, CIOMS 1998 Meyboom RHG, Egberts, ACG. Comparing therapeutic benefit & risk. Therapie 1999; 54: March 2003 Lusaka 16
17 Assessment 9 NEW SIGNAL Evidence for unfavourable change in benefit-harm relationship Options analysis / impact analysis Decision making Implement, communicate Monitor, follow-up 27 March 2003 Lusaka 17
18 Assessment 10 Assessments may change with new information Assessments may be made by comparing the drug with no treatment other available treatment 27 March 2003 Lusaka 18
TITLE: SAFE USE OF MEDICINES IN ZANZIBAR A
Table of content Acknowledgements Introduction TITLE: SAFE USE OF MEDICINES IN ZANZIBAR A guide for health professionals in detecting and reporting adverse drug reaction. (Beautiful photograph tablets
More informationEstablishing Rules for: Medical Device Reports (803) & Correction and Removal Reports (806)
Establishing Rules for: Medical Device Reports (803) & Correction and Removal Reports (806) Presented by: Cap Uldriks, FDA Daniel P. Olivier, CCS Page 1 Objectives Define regulatory reporting rules based
More informationFrequently Asked Questions about Supervised Injecting Facilities 24 July 2014
Frequently Asked Questions about Supervised Injecting Facilities 24 July 2014 1 Q: What are Supervised Injecting Facilities? A: These are places where people who inject drugs can go to inject in relative
More informationSuicide.. Bad Boy Turned Good
Suicide.. Bad Boy Turned Good Ross B Over the last number of years we have had a few of the youth who joined our programme talk about suicide. So why with all the services we have in place is suicide still
More informationRISK ASSESSMENT RISK MANAGEMENT FORMS. Data Protection Act
RISK ASSESSMENT & RISK MANAGEMENT FORMS Data Protection Act Wiltshire Council is subject to the Data Protection Act 1998 regarding information held about a service user, and as such adheres to the eight
More informationTackling Alcohol Misuse Treatment and performance in Derby City
Tackling Alcohol Misuse Treatment and performance in Derby City 2008-2013 Overview Picture of Derby in 2008 start of AHRS Derby s Alcohol Harm Reduction Strategy and NST findings The treatment system 2010-2013
More informationPURPOSE The purpose of the Malaria Control Strategic Plan 2005/ /10 is to provide a common platform and detailed description of interventions
PURPOSE The purpose of the Malaria Control Strategic Plan 2005/06-2009/10 is to provide a common platform and detailed description of interventions for all RBM partners and sectors of society. It encourages
More informationActive TB drug-safety management & monitoring
Active TB drug-safety management & monitoring Global TB Programme, WHO, Switzerland 6 August 2015 Pharmacovigilance: definition of science and activities relating to the detection, assessment, understanding
More informationThe Modified Risk Products. or Protectionism?
The Modified Risk Products Provisions of the FDA Tobacco Act: Science Based Policy or Protectionism? Michael Siegel, MD, MPH Professor Boston University School of Public Health Who Am I? Testified in more
More information8.0 ADVERSE EVENT HANDLING
8.0 ADVERSE EVENT HANDLING In accordance with the U.S. Code of Federal Regulations governing IND safety reports (Code of Federal Regulations 21, 312.32), adverse events (AEs) are reported from research
More informationHow could social media data be relevant to regulatory decision-making?
How could social media data be relevant to regulatory decision-making? Social Media Workshop PCWP and HCPWP Joint meeting 19 September, 2016 June M Raine, MHRA UK An agency of the European Union Social
More informationPHARMACOVIGILANCE GLOSSARY
PHARMACOVIGILANCE GLOSSARY Section 1 Section 2 Section 3 Section 4 Definitions of terminology used for side effects Definitions of drug safety terms Definitions of risk terminology Definitions of general
More informationPrinciples of signal detection. Marie Lindquist
Principles of signal detection Marie Lindquist Pharmacovigilance endpoints What we do should support good decision making in relation to medication therapy to maximise treatment effectiveness to reduce
More informationKNOW YOUR BODY SPOT CANCER EARLY PROSTATE CANCER
KNOW YOUR BODY SPOT CANCER EARLY PROSTATE CANCER TAKE CHARGE Whether you ve heard about it from a friend or family member, seen it in the news, or are just curious: if you want to know more about spotting
More informationPatient Preference for Outcomes in Critical Care Studies
Patient Preference for Outcomes in Critical Care Studies Dr. John Muscedere Critical Care Program, Kingston General Hospital Professor of Medicine, Queens University Scientific Director, TVN Conflicts
More informationSaint Louis University Institutional Review Board Ionizing Radiation Risk Informed Consent Template Language
Saint Louis University Institutional Review Board Ionizing Radiation Risk Informed Consent Template Language Does the study involve research-related exposure to ionizing radiation? That is, will study
More informationYukon School Immunization Program Grade 6 INFORMATION FOR PARENTS/GUARDIANS
Yukon School Immunization Program Grade 6 INFORMATION FOR PARENTS/GUARDIANS July 2018 Read the information in this booklet. Complete, sign and return the Immunization Consent Form that came with this booklet.
More informationSTROKE INTRODUCTION OBJECTIVES. When the student has finished this module, he/she will be able to:
STROKE INTRODUCTION Stroke is the medical term for a specific type of neurological event that causes damage to the brain. There are two types of stroke, but both types of stroke cause the same type of
More informationPublic Health Screening Programmes Annual Report 1 April 2013 to 31 March 2014
Greater Glasgow and Clyde NHS Board Board Meeting 21 April 2015 Board Paper No: 15/13 Director of Public Health Public Health Screening Programmes Annual Report 1 April 2013 to 31 March 2014 RECOMMENDATION
More informationEmerging Respiratory Infections NZ Amanda McNaughton Respiratory Physician CCDHB Wellington
Emerging Respiratory Infections NZ 2015 Amanda McNaughton Respiratory Physician CCDHB Wellington Respiratory Infection: overview Influenza virus Clinical picture Emerging infection New Zealand Influenza
More informationAdverse Events Following Immunisation. Castlebar, Nov. 8, 2013 Kevin Connolly
Adverse Events Following Immunisation Castlebar, Nov. 8, 2013 Kevin Connolly Outline of presentation Definitions Safety assessment Timing of reactions Causality-real and coincidence Errors Occasional diversions
More informationThreat to Self: Suicide & Self-Injurious Behavior. David Towle, Ph.D. UNI Counseling Center Director
Threat to Self: Suicide & Self-Injurious Behavior David Towle, Ph.D. UNI Counseling Center Director What do you do? You check your e-mail and find a message from a student, apparently sent about 3 a.m.,
More informationRisk Interpretation and Action
Risk Interpretation and Action J. Richard Eiser 1, Ann Bostrom 2, Ian Burton 3, David Johnston 4, John McClure 5, Douglas Paton 6, Joop van der Pligt 7, Mathew White 8. 1 University of Sheffield, UK; 2
More information1. Introduction to Pharmacovigilance
1. Introduction to Pharmacovigilance The science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems. 1.1 Glossary of
More informationThis research paper sample is provided by SpecialEssays.com the best custom writing
Student s Last Name 1 This research paper sample is provided by SpecialEssays.com the best custom writing company online. Our prices start at $11.99. Get your paper of the highest quality now and succeed
More informationGuideline scope Smoking cessation interventions and services
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Topic NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Smoking cessation interventions and services This guideline
More informationSession 7: The Sliding Dichotomy 7.1 Background 7.2 Principles 7.3 Hypothetical example 7.4 Implementation 7.5 Example: CRASH Trial
Session 7: The Sliding Dichotomy 7.1 Background 7.2 Principles 7.3 Hypothetical example 7.4 Implementation 7.5 Example: CRASH Trial Session 7 1 7.1 The Sliding Dichotomy: Background The sliding dichotomy
More informationRTS,S Malaria Vaccine Implementation Programme A joint initiative of GMP & IVB
RTS,S Malaria Vaccine Implementation Programme A joint initiative of GMP & IVB Update to the Malaria Policy Advisory Committee David Schellenberg, Scientific Advisor, GMP Mary Hamel, Coordinator MVIP,
More information1.1. An overview of reports on sitagliptin
1.1. An overview of reports on Introduction Sitagliptin (Januvia ) was registered for the European marked on March 21 st 27 with the Netherlands as rapporteur. It is indicated as treatment of for patients
More informationHow to end homelessness in Great Britain
How to end homelessness in Great Britain I always thought homelessness was just rough sleeping... But it s people in unsuitable and temporary accommodation too... Having somewhere safe and stable to live
More informationPrescription Event Monitoring
Prescription Event Monitoring David Coulter NZ Intensive Medicines Monitoring Programme 27 March 2003 Lusaka 1 PEM worldwide NZ Intensive Medicines Monitoring Programme (IMMP), Dunedin, 1977 Drug Safety
More informationHot Topics in Healthcare Osher Lifelong Learning Institute University of California at San Diego. October 17, 2017
Hot Topics in Healthcare Osher Lifelong Learning Institute University of California at San Diego October 17, 2017 Format Notes Speakers present pro and con perspectives Goal is to inform..not have one
More informationHealth Security in Southeast Asia
Health Security in Southeast Asia J. Kevin Baird, Ph.D. P.T. Hygienica Jakarta Health Risks & Security What is health security? Awareness of possible threats Monitoring likely threats Minimizing likely
More informationSmoking cessation in mental health & addiction settings. Dr. Susanna Galea Community Alcohol & Drug Services, Auckland October 2013
Smoking cessation in mental health & addiction settings Dr. Susanna Galea Community Alcohol & Drug Services, Auckland October 2013 OVERVIEW Tobacco is the single most preventable cause of death in the
More informationUnanticipated Problems and Adverse Events
Unanticipated Problems and Adverse Events David Borasky, MPH, CIP Office of Research Protections RTI International Research Triangle Park, North Carolina, USA Introduction IEC review of unanticipated problems
More informationGoing smokefree. Why are we smokefree? Information for service users, families, carers and supporters
Going smokefree Leaflet reference: L918E Version: V4 Date last updated: 09 / 01 / 2017 Archive date: 09 / 01 / 2020 Information for service users, families, carers and supporters Why are we smokefree?
More informationAdverse Events Monitoring (aka Pharmacovigilance)
Adverse Events Monitoring (aka Pharmacovigilance) Presentation to American Conference Institute s FDA Boot Camp William W. Vodra May 16, 2007 Agenda What is pharmacovigilance (PV)? How does PV use adverse
More informationRegulatory Aspects of Pharmacovigilance
Regulatory Aspects of Pharmacovigilance Deirdre Mc Carthy Pia Caduff-Janosa Training Course Uppsala 2013 Agenda Risk based approach to spontaneous reporting (incl clinical trials) -> Pia Caduff-Janosa
More informationTRENDS IN SUBSTANCE USE AND ASSOCIATED HEALTH PROBLEMS
Fact Sheet N 127 August 1996 TRENDS IN SUBSTANCE USE AND ASSOCIATED HEALTH PROBLEMS Psychoactive substance use is an increasing public health concern. Problems associated with this use cover a broad spectrum
More informationMental Health Strategy. Easy Read
Mental Health Strategy Easy Read Mental Health Strategy Easy Read The Scottish Government, Edinburgh 2012 Crown copyright 2012 You may re-use this information (excluding logos and images) free of charge
More informationAdult Patient Information and Consent Form
The ROAM Trial Radiation versus Observation following surgical resection of Atypical Meningioma: a randomised controlled trial
More informationTAXOTERE: WHAT YOU NEED TO KNOW ABOUT IT
TAXOTERE: WHAT YOU NEED TO KNOW ABOUT IT 1 Fighting breast cancer is a very emotional battle for women. Doctors are trying to save the lives of women by trying new and innovative methods and drugs. One
More informationAbdominal aortic aneurysm (AAA) screening Things you need to know
Abdominal aortic aneurysm (AAA) screening Things you need to know A quick, free and painless scan for men aged 65 and over Who is this leaflet for? This leaflet is for all men aged 65 and over who live
More informationCost of Injury in Canada Ontario Highlights
Cost of Injury in Canada Ontario Highlights Webinar will begin at 1:00 pm Audio Join us on the line! Ø Toll-free: 1.866.261.6767 Ø Participant code: 18652131# The Cost of Injury in Canada Ontario Highlights
More informationNewborn Bloodspot Screening Information for parents
Newborn Bloodspot Screening Information for parents You will be offered a bloodspot screening test for your newborn baby for several rare but serious conditions. The sample for this test is usually taken
More informationImproving Return on Public Health Investments in Disasters with Evidence Synthesis
Improving Return on Public Health Investments in Disasters with Evidence Synthesis Karen A. Robinson Johns Hopkins University Evidence Aid 17 Nov 2016 Evidence Synthesis Formal methods for summarizing
More informationCANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE
1 CANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE The Health Effects of Cannabis and Cannabinoids. The Current State of Evidence and Recommendations
More informationMethadone Diversion: Why it happens, what the illicit market looks like and the implications
Methadone Diversion: Why it happens, what the illicit market looks like and the implications Paul Duffy & Helen Baldwin Centre for Public Health Liverpool John Moores University Methadone provision and
More informationNHS Breast Screening Programme
NHS Breast Screening Programme Over 70? You can still have breast screening if you choose Public Health England leads the NHS Screening Programmes Breast screening Breast screening is a way of detecting
More informationNewborn Bloodspot Screening Information for parents
Newborn Bloodspot Screening Information for parents You will be offered a bloodspot screening test for your newborn baby for several rare but serious conditions. The sample for this test is usually taken
More informationHalving fractured hips in New Zealand public hospitals September Sandy Blake National Clinical Lead, Reducing Harm from Falls Programme
Halving fractured hips in New Zealand public hospitals September 2017 Sandy Blake National Clinical Lead, Reducing Harm from Falls Programme Health regions New Zealand Context The approach is individualised
More informationCROWDSOURCING AND MEDICINE BOB MARSHALL, MD MPH MISM FAAFP FACULTY, DOD CLINICAL INFORMATICS FELLOWSHIP
CROWDSOURCING AND MEDICINE BOB MARSHALL, MD MPH MISM FAAFP FACULTY, DOD CLINICAL INFORMATICS FELLOWSHIP OBJECTIVES WHAT IS CROWDSOURCING? Term coined in 2006 by Wired Magazine editors The process of obtaining
More informationGene Expression and Mutation
Gene Expression and Mutation GENE EXPRESSION: There are hormonal and environmental factors that may cause the expression of some genetic information. Some examples are: 1. The two- colour pattern of some
More informationGlobal Advisory Committee on Vaccine Safety (GACVS) Report from the June 2017 meeting
Global Advisory Committee on Vaccine Safety (GACVS) Report from the June 2017 meeting Topics discussed in June Safety monitoring of the RTS,S vaccine pilot implementation programme Safety update of BCG
More informationWhy do we Fall ill IX Science C.B.S.E. Practice Paper Page 81
13. Why do we Fall ill Q 1 Write the name of the organism that causes kala-azar. Q 2 What is a disease? Q 3 Write one example of both infectious and non-infectious disease? Q 4 Which type of disease is
More informationClinical risk management in community pharmacy - Henk Buurma SUMMARY
SUMMARY Summary This thesis starts with an introduction (Chapter 1) in which an overview of the recent history of community pharmacy practice is presented, and in which we elaborate on the evolving role
More informationGRADE tables to assist guideline development and recommendations. Plain Language Summary of Results
Seasonal Malaria Chemoprevention (formally known as Intermittent Preventive Treatment in children) for preventing malaria morbidity in children aged less than 5 years living in areas of marked seasonal
More informationFive Things the Family Physician Needs to Know about Addiction and Harm Reduction
Five Things the Family Physician Needs to Know about Addiction and Harm Reduction Dr. Sharon Koivu Palliative Care Physician Consultant, London Health Sciences Centre, Department of Family Medicine, Western
More informationNHTSA s Ease of Use Rating System for Child Restraint Systems
Transmitted by the expert from the United States of America NHTSA s Ease of Use Rating System for Child Restraint Systems Informal document No. GRSP-43-14 (43rd GRSP, 19-23 May 2008 agenda items 12(a))
More informationCancer Screening Programmes BREAST SCREENING. The Facts LARGE PRINT
Cancer Screening Programmes BREAST SCREENING The Facts LARGE PRINT What is breast screening? Breast screening (mammography) is an x-ray examination of the breasts. Breast screening can show breast cancers
More informationDrink Driving Fast Facts Draft
Drink Driving Fast Facts Draft Any alcohol impairs driving and increases the risk of a collision. This is not an opinion it s a scientific fact. Alcohol is a factor in 38% of fatal crashes o 29% of all
More informationKaren R Steingart, MD, MPH Madhu Pai, MD, PhD David Dowdy, MD Berlin, 11 November 2010
Karen R Steingart, MD, MPH Madhu Pai, MD, PhD David Dowdy, MD Berlin, 11 November 2010 I serve as co-chair of the Evidence Synthesis subgroup of Stop TB Partnership s New Diagnostics Working Group I am
More informationCOMMITMENT TO A TOBACCO ENDGAME IN ONTARIO
COMMITMENT TO A TOBACCO ENDGAME IN ONTARIO Our Ask That the Ontario government: Renew their commitment to achieving the lowest smoking rate in Canada Align the Smoke Free Ontario Strategy with the proposed
More informationCommunity mobilization in major emergencies
COMMUNITY TOOLS Tool 1 Community mobilization in major emergencies Response: What do you see in these pictures? Disasters that can affect a community such as earthquakes or floods. What are some other
More informationSystem and Role of Pharmacovigilance in Implementing the Ukraine National TB Control Program
System and Role of Pharmacovigilance in Implementing the Ukraine National TB Control Program Irina Logvina Center for Drug Evaluation and Research, Ukrainian MH Antalya, Turkey December 10-13, 2013 Ukraine
More informationKey Findings from the ISMP Canada Safety Bulletins Drugs: Oversight, Safety and Supply OHA Educational Event November 20, 2015 Toronto, ON
Key Findings from the ISMP Canada Safety Bulletins Drugs: Oversight, Safety and Supply OHA Educational Event November 20, 2015 Toronto, ON David U President & CEO ISMP Canada Ontario Critical Incident
More informationIntervening at l Autre Maison Crisis Center
Intervening at l Autre Maison Crisis Center Cindy Subaihi Jessy Paul-Hus Mental Health workers, L Autre Maison Crisis Center Presented at the Douglas Mental Health University Institute November 25, 2016
More informationThe dramatic effect of the one risk you can t see
The dramatic effect of the one risk you can t see The reclassification of hearing protection under PPE Regulation (EU) 2016/425 and what it means for you protecting people The World Health Organisation
More informationFREE breast screening every two years for women aged 45 to 69
FREE breast screening every two years for women aged 45 to 69 Early detection is your best protection Do I need breast screening? Nearly 10 percent of New Zealand women will develop breast cancer in their
More informationClinical Measurement of Drug Action
1 Clinical Measurement of Drug Action Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland 2 The $1,000,000 Questions Is this drug effective? - is it better than a competitor/alternative?
More informationLISTEN! You might be going deaf DEPARTMENT OF LABOUR TE TARI MAHI OCCUPATIONAL SAFETY & HEALTH SERVICE
LISTEN! You might be going deaf OCCUPATIONAL SAFETY & HEALTH SERVICE 1 DEPARTMENT OF LABOUR TE TARI MAHI GET THE ANSWERS ABOUT HOW NOISE AFFECTS YOU. Issued by the Occupational Safety & Health Service,
More informationPCNE 3rd Medication Review Workshop 1
PCNE 3rd Medication Review Workshop 1 Leuven, 29th May 2012 Facilitators: Foppe van Mil, Pharmacy Practice Consultant, Zuidlaren, The Netherlands Charlotte Rossing, Head of Research & Development, Pharmakon,
More informationMaking Safeguarding Personal Staff Guide. Stopping Adult Abuse Everyone's Business
Making Safeguarding Personal Staff Guide Stopping Adult Abuse Everyone's Business Background The Care Act 2014 has changed the approach to safeguarding adults at risk of harm. Making Safeguarding Personal
More informationVaccine assessment for prequalification
Vaccine assessment for prequalification Briefing on Vaccine Prequalification for manufacturers DCVMN meeting, Kunming, China, 13 March 2016 Olivier Lapujade World Health Organization, EMP/RHT/PQT lapujadeo@who.int
More informationFactor VIII Concentrate Factor IX Complex (Coagulation Factors, II, VII, IX, X) Concentrate. From: European Plasma Fractionation Association (EPFA)
Factor VIII Concentrate Factor IX Complex (Coagulation Factors, II, VII, IX, X) Concentrate Application for retention on the WHO Model List From: European Plasma Fractionation Association (EPFA) 1. Summary
More informationAnnex 2. GRADE glossary and summary of evidence tables
WHO/HTM/TB/2011.6b. GRADE glossary and summary of evidence tables GRADE glossary Absolute effect The absolute measure of intervention effects is the difference between the baseline risk of an outcome (for
More informationLiving Healthy , The Patient Education Institute, Inc. hp Last reviewed: 03/30/2017 1
Living Healthy Introduction Most diseases that cause disability and death among Americans can be prevented or delayed. Practicing healthy living habits and having regular medical screenings can help you
More informationSPOTTING THE SIGNS OF CANCER FOR MEN
SPOTTING THE SIGNS OF CANCER FOR MEN Thousands of people survive cancer every year. When cancer is diagnosed at an early stage, treatment is more likely to be successful. So finding cancer early can make
More informationPharmacovigilance in HIV/AIDS Public Health Programmes: Luxury or Priority?
Pharmacovigilance in HIV/AIDS Public Health Programmes: Luxury or Priority? Micheline Diepart WHO HIV/AIDS ATC Launching a Three-Year Initiative Developing pharmacovigilance (PV) for antiretroviral medicines
More informationI protected my future
I protected my future I had all my vaccinations Ask at home today if you ve had your vaccinations. Developed by Pfizer Ltd in collaboration with PHE and Wiltshire Council. March 2014. NPSC0069c Everybody
More informationSeverity Metrics. Gary Ezzell, Ph.D. Mayo Clinic Arizona
Severity Metrics Gary Ezzell, Ph.D. Mayo Clinic Arizona Learning Objectives Understand the purpose and use of severity metrics in an incident learning system Review examples of severity metrics that have
More informationROAD SAFETY (OR LACK THEREOF) IN THE PUBLIC MIND
ROAD SAFETY (OR LACK THEREOF) IN THE PUBLIC MIND INVESTIGATING TOLERANCE OF UNSAFE ROAD CONDITIONS AND BEHAVIOURS AMONG DRIVER S LICENCE HOLDERS IN QUEBEC November 2011 SUMMARY There is a fairly widespread
More informationPharmacovigilance and Reporting Adverse Drug Reactions
EDITORIAL Med & Health 2014; 9(2): 92-102 Pharmacovigilance and Reporting Adverse Drug Reactions ISA NM Pharmacoepidemiology and Drug Safety Unit, Department of Pharmacology, Faculty of Medicine, Universiti
More informationMath Released Item Algebra 2. Percent False Positives VF866689
Math Released Item 2016 Algebra 2 Percent False Positives VF866689 Prompt Rubric Task is worth a total of 6 points, 4 points are scored using the rubric. VF866689 Rubric Part A Score Description 2 Student
More informationPsychological Factors Influencing People s Reactions to Risk Information. Katherine A. McComas, Ph.D. University of Maryland
Psychological Factors Influencing People s Reactions to Risk Information Katherine A. McComas, Ph.D. University of Maryland What This Tutorial Covers Reasons for understanding people s risk perceptions
More informationMedical Marijuana: The Move to Schedule II
Medical Marijuana: The Move to Schedule II David Deitz, MD, PhD David Deitz & Associates Today s discussion Does medical marijuana actually treat anything? What are the workplace issues? What are the interactions
More informationDementia: modelling interventions, costs and outcomes
Dementia: modelling interventions, costs and outcomes Evaluation of public policies for sustainable Long-Term Care in Spain Workshop Barcelona, 3 rd July 2014 Adelina Comas-Herrera PSSRU London School
More informationWHO INFLUENZA VACCINE RECOMMENDATION
WHO INFLUENZA VACCINE RECOMMENDATION Strategic Advisory Group of Experts (SAGE) on Immunization SAGE Working Group on Influenza Vaccine and Immunization 1 Evidence Evaluation: Conceptual Matrix Target
More informationIMPAIRED DRIVING ISSUES DAVID ANDRASCIK PA DUI ASSOCIATION DRUG EVALUATION AND CLASSIFICATION PROGRAM STATE COORDINATOR
IMPAIRED DRIVING ISSUES DAVID ANDRASCIK PA DUI ASSOCIATION DRUG EVALUATION AND CLASSIFICATION PROGRAM STATE COORDINATOR OVER 10,000 IMPAIRED DRIVING CRASHES ON OUR HIGHWAYS EACH YEAR (27+EACH DAY) NEARLY
More informationPublic Health Outcomes Framework Key changes and updates for Peterborough: November 2017
Public Health Outcomes Framework Key changes and updates for Peterborough: November 2017 Introduction and overview The Department of Health first published the Public Health Outcomes Framework (PHOF) for
More informationAn overview of reports on lacosamide
An overview of reports on lacosamide Introduction Lacosamide (Vimpat ) was registered for the European market on August 29th 2008. Since then Lareb has received several reports of possible adverse drug
More informationThis document outlines the clinical risks assessed as AFAP within INRstar.
INRstar Anticoagulation Decision Support Software Residual s As Far As Possible ( AFAP ) Background Anticoagulation is an inherently risky process It offers measurable benefits to patients in the reduction
More informationAnnex II. Scientific conclusions
Annex II Scientific conclusions 7 Scientific conclusions Overall summary of the scientific evaluation of methadone products for oral use containing povidone Methadone is a synthetic opioid. Methadone is
More informationSTART THESM CONVERSATION PERSONAL MEDICAL PREFERENCES TEST INSTRUCTIONS:
PERSONAL MEDICAL PREFERENCES TEST How well does your family, agent, or doctor know your health care wishes? This short test can give you some sense of how well you have communicated your wishes to them
More informationCancer Screening Programmes BREAST SCREENING. The Facts
Cancer Screening Programmes BREAST SCREENING The Facts What is breast screening? Breast screening (mammography) is an x ray examination of the breasts. Breast screening can show breast cancers at an early
More informationMODEL CHURCH POLICIES
MODEL CHURCH POLICIES Model Church Policies Policy for the Methodist Church 2010 Approved by the Methodist Conference 2010 The Methodist Church, Methodist Church House, 25 Marylebone Road, London NW1 5JR
More informationConnecting Health & Housing: Asthma and the Home. Presented by: The California-Nevada Public Health Training Center
Connecting Health & Housing: Asthma and the Home Presented by: The California-Nevada Public Health Training Center Funded by Grant #UB6HP20202 from the Health Resources and Services Administration, U.S.
More informationIllogical Inductive Conversions
Chapter 11, Part 7 Illogical Inductive Conversions One more caution regarding inductive reasoning: Stats show that of drivers involved in fatal crashes, 40% are under 26 years old. Therefore, if you re
More informationImage of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS
Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS APRIL 2017 Infectious viruses are a global health threat Since the approval of the first antiviral drug
More informationThe Future of Telehealth in NZ. Craig Lett Head of Innovation Triton Hearing
The Future of Telehealth in NZ Craig Lett Head of Innovation Triton Hearing Overview Background Why consider telehealth? Population trends Benefits of telehealth Case study 1: TeleAudiology Case study
More information